InsidersTradesSigma
Explore the full record of transactions filed by Hatfield Jeffrey S., Director. Director active across 1 company, notably Vir Biotechnology, Inc.. Aggregated, 3 reports have been logged. History available since 21 May 2021. The latest transaction was disclosed on 23 May 2022 (Attribution). Regulator: SEC (Form 4). All data is openly available.
3 of 3 declarations
Jeffrey S. Hatfield is a Director at Vir Biotechnology, Inc. As a board member, he participates in overseeing operations and strategic decision-making. His experience is valuable in guiding the company's direction.